• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠腺癌中直肠系膜分级与肿瘤学结局的关系。

The relationship between mesorectal grading and oncological outcome in rectal adenocarcinoma.

机构信息

Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Colorectal Dis. 2019 Mar;21(3):315-325. doi: 10.1111/codi.14535. Epub 2019 Jan 17.

DOI:10.1111/codi.14535
PMID:30565830
Abstract

AIM

The prognostic association between mesorectal grading and oncological outcome in patients undergoing resection for rectal adenocarcinoma is controversial. The aim of this retrospective chart review was to determine the individual impact of mesorectal grading on rectal cancer outcomes.

METHOD

We compared oncological outcomes in patients with complete, near-complete and incomplete mesorectum who underwent rectal excision with curative intent from 2009 to 2014 for Stage cI-III rectal adenocarcinoma. We also assessed the independent association of mesorectal grading and oncological outcome using multivariate models including other relevant variables.

RESULTS

Out of 505 patients (339 men, median age of 60 years), 347 (69%) underwent a restorative procedure. There were 452 (89.5%), 33 (6.5%) and 20 (4%) patients with a complete, near-complete and incomplete mesorectum, respectively. Local recurrence was seen in 2.4% (n = 12) patients after a mean follow-up of 3.1 ± 1.7 years. Unadjusted 3-year Kaplan-Meier analysis by mesorectal grade showed decreased rates of overall, disease-free and cancer-specific survival and increased rates of overall and distant recurrence with a near-complete mesorectum, while local recurrence was increased in cases of an incomplete mesorectum (all P < 0.05). On multivariate analyses, a near-complete mesorectum was independently associated with decreased cancer-specific survival (hazard ratio 0.26, 95% CI 0.1-0.7; P = 0.007). There were no associations between mesorectal grading and overall survival, disease-free survival, overall recurrence or distant recurrence (all P > 0.05).

CONCLUSION

Mesorectal grading is independently associated with oncological outcome. It provides unique information for optimizing surgical quality in rectal cancer.

摘要

目的

在接受直肠腺癌切除术的患者中,中直肠分级与肿瘤学结果之间的预后相关性存在争议。本回顾性图表回顾的目的是确定中直肠分级对直肠癌结果的个体影响。

方法

我们比较了 2009 年至 2014 年间接受根治性直肠切除术治疗 cI-III 期直肠腺癌的完全、接近完全和不完全中直肠患者的肿瘤学结果。我们还使用包括其他相关变量的多变量模型评估了中直肠分级和肿瘤学结果的独立关联。

结果

在 505 名患者(339 名男性,中位年龄 60 岁)中,347 名(69%)接受了恢复性手术。分别有 452 名(89.5%)、33 名(6.5%)和 20 名(4%)患者的中直肠完全、接近完全和不完全。在平均随访 3.1±1.7 年后,2.4%(n=12)的患者出现局部复发。未调整的 3 年 Kaplan-Meier 分析显示,中直肠分级为接近完全时,总生存率、无病生存率和癌症特异性生存率降低,总复发率和远处复发率增加,而中直肠不完全时局部复发率增加(均 P<0.05)。多变量分析显示,接近完全的中直肠与癌症特异性生存率降低独立相关(风险比 0.26,95%CI 0.1-0.7;P=0.007)。中直肠分级与总生存率、无病生存率、总复发率或远处复发率之间无关联(均 P>0.05)。

结论

中直肠分级与肿瘤学结果独立相关。它为优化直肠癌的手术质量提供了独特的信息。

相似文献

1
The relationship between mesorectal grading and oncological outcome in rectal adenocarcinoma.直肠腺癌中直肠系膜分级与肿瘤学结局的关系。
Colorectal Dis. 2019 Mar;21(3):315-325. doi: 10.1111/codi.14535. Epub 2019 Jan 17.
2
Factors associated with noncomplete mesorectal excision following surgery for rectal adenocarcinoma.直肠腺癌手术后非完整中直肠系膜切除的相关因素。
Am J Surg. 2019 Mar;217(3):465-468. doi: 10.1016/j.amjsurg.2018.10.051. Epub 2018 Nov 14.
3
Mesorectal grades predict recurrences after curative resection for rectal cancer.直肠系膜分级可预测直肠癌根治性切除术后的复发情况。
Dis Colon Rectum. 2007 Feb;50(2):168-75. doi: 10.1007/s10350-006-0756-2.
4
Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.新辅助放化疗后直肠癌直肠系膜分级的长期预后价值
Am J Surg. 2014 Sep;208(3):332-41. doi: 10.1016/j.amjsurg.2013.10.023. Epub 2014 Jan 17.
5
Local recurrence in patients treated for rectal cancer using total mesorectal excision or transection of mesorectum.接受全直肠系膜切除术或直肠系膜横断术治疗的直肠癌患者的局部复发情况。
Vojnosanit Pregl. 2016 Oct;73(10):927-33. doi: 10.2298/VSP150430092M.
6
Suboptimal surgery and omission of neoadjuvant therapy for upper rectal cancer is associated with a high risk of local recurrence.高位直肠癌手术不充分及新辅助治疗的遗漏与局部复发的高风险相关。
Colorectal Dis. 2015 Mar;17(3):216-24. doi: 10.1111/codi.12869.
7
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.直肠癌的放化疗联合局部切除保肛治疗:GRECCAR 2 随机试验的 5 年结果。
Lancet Gastroenterol Hepatol. 2020 May;5(5):465-474. doi: 10.1016/S2468-1253(19)30410-8. Epub 2020 Feb 7.
8
Factors that influence the adequacy of total mesorectal excision for rectal cancer.影响直肠癌全直肠系膜切除充分性的因素。
Colorectal Dis. 2007 Nov;9(9):808-15. doi: 10.1111/j.1463-1318.2007.01256.x. Epub 2007 Apr 18.
9
Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome.直肠癌的局部直肠系膜切除术:发病率和肿瘤学结局
Clin Colorectal Cancer. 2016 Mar;15(1):82-90.e1. doi: 10.1016/j.clcc.2015.07.008. Epub 2015 Aug 1.
10
Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database.机器人直肠癌根治术后的肿瘤学结果:前瞻性数据库分析。
Ann Surg. 2018 Mar;267(3):521-526. doi: 10.1097/SLA.0000000000002112.

引用本文的文献

1
Total mesorectal excision quality in rectal cancer surgery affects local recurrence rate but not distant recurrence and survival: population-based cohort study.直肠癌手术中全直肠系膜切除质量影响局部复发率,但不影响远处复发和生存率:基于人群的队列研究。
BJS Open. 2024 Jul 2;8(4). doi: 10.1093/bjsopen/zrae071.
2
Lower conversion rate with robotic assisted rectal resections compared with conventional laparoscopy; a national cohort study.与传统腹腔镜相比,机器人辅助直肠切除术的转化率较低;一项全国性队列研究。
Surg Endosc. 2022 May;36(5):3574-3584. doi: 10.1007/s00464-021-08681-x. Epub 2021 Aug 18.
3
Adjuvant therapy in patients with rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and radical resection in pathological stages I-III.
对病理分期为I-III期的直肠腺癌患者,在接受新辅助放化疗和根治性切除术后进行辅助治疗。
Ann Transl Med. 2020 Sep;8(17):1116. doi: 10.21037/atm-20-5088.